Veda Giri
@vedangiri
Followers
440
Following
169
Statuses
150
Division Chief, Clinical Cancer Genetics, Yale School of Medicine; Asst Director, Clinical Cancer Genetics, Yale Cancer Center; Opinions my own
YSM, YCC, Smilow Cancer Hosp
Joined March 2017
Important symposium on fertility preservation which impacts patients with early onset cancer and their families. Discussed state-of-the-art care and multi-D programs. @SmilowCancer @YaleCancer @YaleMed
Important education and conversation on #fertility care for patients with #cancer and hematological disorders at our “Preserving Hope” conference hosted by @DrEricWiner, Dr. Hugh Taylor, @vedangiri, and Dr. Nancy Borstelmann. @YaleCancer @YaleMed @YNHH
0
0
4
Honored to work with expert colleagues nationally and globally for this effort. We hope this will be a helpful model to reduce PCA disparities in genetic testing. @YaleCancer @YaleMed
A socioecological model proposed in this new study from @vedangiri et al implements equitable strategies dedicated to ⬆️engagement of Black males in #prostatecancer genetic testing which is critical to ⬇️ disparities in mortality. @SmilowCancer @YaleMed @YNHH @BMC_series
0
1
5
It was a terrific forum and honored to have been a part of it! @PCFnews #WomenInScience
The @PCFnews #WomenInScience Forum: Empowering female researchers through networking and mentorship. @vedangiri, @AyeshaShafi_PhD, & @Fletcher_C join @AndreaMiyahira in this discussion on UroToday >
3
1
13
Totally agree! What a fun and inspiring group! @ASCO
I’m so proud to be part of this brilliant and fun @ASCO #guidelines group! @EnriqueSoto8 @vedangiri @BryanRumble @BrittanyEHarvey and more!
0
0
5
Excited for the Early Onset Cancer Program to improve outcomes and quality of life for younger adults with cancer, their families, and their loved ones. @YaleCancer
Our Early Onset Cancer Program focuses on patients with #cancer btw ages 18-49 + will address psychosocial needs, novel clinical care models, enhance #clinicaltrials, expand research, and community awareness. @SmilowCancer @YaleMed @YNHH @vedangiri
0
0
11
Thank you @urotoday and @CaPsurvivorship for opportunity to highlight TARGET study results at ASCO 2023! Excited to have worked with terrific collaborators @LoebStacy @heatherhcheng
Patient-driven webtool challenges traditional counseling in #ProstateCancer germline testing. @vedangiri @YaleCancer joins @CaPsurvivorship @DanaFarber to discuss the promising results of the #TARGET study on UroToday >
0
2
14
What a wonderful conference- surrounded by brilliant minds coming together to address big questions to reduce PCA mortality #PCFAcademy @PCF_Science
Wonderful start to session II on implementation of genetic testing by Dr. Veda Giri @vedangiri highlighting current PCa studies designed to evaluate different design/methods of implantations. #PCFAcademy @PCF_Science
0
2
8
It was my pleasure! Wonderful to build collaborations with Urology colleagues and reconnect with an esteemed Visiting Professor!
A special thanks to @vedangiri, MD, for our showcase talk today! "Urology is a key gateway into identifying hereditary cancer..." @YaleMed #VisitingProfessorDay #genetics
0
0
8
@BryanRumble @arkhaki @mullane_michael @MattGubensMD @DrScottTagawa @geisel_rachel @BeverlyMoy @RohanGarjeMD @Brouwer_MD_PhD @KimrynRathmell Love working with you all! What a great meeting!
0
0
4
Such an honor to serve as Chair of ASCO Evidence Based Medicine Committee this year - what a terrific ASCO team! #ASCO2023 @BrittanyEHarvey @geisel_rachel @BryanRumble
2
3
16
Very excited to work with a stellar team of investigators @LoebStacy @heatherhcheng for the TARGET study. Grateful for PCF Challenge Award funding @PCFnews @PCF_Science #ASCO2023
.@vedangiri shares new research supporting a new standard of care for the use of patient-driven web tools for expanding access to decision making for genetic testing. @OncoAlert @SmilowCancer @YaleMed @YNHH
0
4
8
Grateful to work with an excellent team of investigators for PROGRESS Registry. Many thanks to @young_whang for presenting the abstract. Thank you @urotoday for article and enhancing impact!@YaleCancer @SmilowCancer @YNHH
Today at 2:30pm EST, Dr. Veda Giri @vedangiri presents "Factors related to men's experience with #prostatecancer germline testing" during Poster Session A at @ASCO GU Cancers Symposium #GU23. @SmilowCancer @YaleMed @YNHH
0
1
7
We all can make a difference during #NationalCancerPreventionMonth and beyond by spreading the message of importance of cancer screening, healthy lifestyle, and knowing family history of cancer-one individual, family, and community at a time! @YaleCancer
February is #NationalCancerPreventionMonth. Learn more about #cancer risk and hereditary #cancergenetics at our webinar, "Smilow Shares: Understanding Your Cancer Risk and Prevention," on Feb. 23 at 7pm. Register: @vedangiri
@SmilowCancer @YaleMed @YNHH
0
1
5
RT @UrologyTimes: New podcast series offering information on genetic testing for prostate cancer has featured medical oncologists, genetic…
0
4
0
RT @LoebStacy: On this week's Prostate Cancer Genetics Podcast, @vedangiri and I spoke to a patient with #prostatecancer about his experien…
0
5
0
RT @LoebStacy: New prospective data that PODCASTS are a useful way to share education about #prostatecancer genetics! Hot off the press in…
0
1
0
RT @LoebStacy: Hot off the press: Genetic Risk Prediction for #ProstateCancer: Implications for Early Detection and Prevention HT @TylerSb…
0
6
0
RT @UrologyTimes: Experts study implications of genetic markers in prostate cancer #urology #urologist #prostatecan…
0
2
0
Great working with ASCO team on this exciting new pathway for guidelines #ASCO
@ASCO's #livingguideline methodology represents the future of guideline development. Great working w/ @BryanRumble, @vedangiri, #TomOliver and @JCO_ASCO editors Jonathan Friedberg & Kathy Miller on this editorial:
0
0
2
RT @ResearchWyatt: Involved with genomic testing in prostate cancer? Please take our survey - it is for anyone in c…
0
16
0